The Pennsylvania Biotechnology Center in Doylestown is putting its growth plans on hold, hitting pause on a campus expansion and zeroing in on filling the lab and office space it already has. The move comes as early-stage life sciences companies run into a tougher fundraising climate, with seed and Series A capital getting harder to secure and growth projects at incubators around the country slowing down.
As reported by the Philadelphia Business Journal, the Bucks County hub has stopped its planned buildout and is redirecting resources to leasing and tenant support. The outlet notes that early-stage life sciences outfits are facing "ongoing challenges" raising capital, which is now rippling through the region’s biotech infrastructure.
Why the expansion stalled
The Pennsylvania Biotechnology Center operates two locations, its Doylestown campus and B+labs at Cira Centre, and its website reports nearly 70 companies across both sites, with the Doylestown facility hosting roughly 50 early-stage firms. The center’s facilities pages also advertise available lab benches, shared equipment, and business services as management works to turn that open space into paid leases, according to PABC.
State funding vs. private investment
According to the Commonwealth of Pennsylvania, the 2026–27 budget includes $125 million for Innovate in PA 2.0 to support startups and build a statewide clinical trial network. That kind of state-level backing may help patch some holes in the funding picture, but incubators still lean heavily on private venture money to justify large new lab buildings and long-term leases.
Earlier plans showed momentum
As recently as October 2025, the Philadelphia Business Journal reported that PABC was eyeing a 2.85-acre parcel owned by Fred Beans Automotive for a roughly 30,000 to 35,000 square foot lab and office building, and that the Bucks County Industrial Development Authority had secured a $150,000 PA SITES planning grant for an engineering feasibility study. Those plans are now on hold while PABC concentrates on leasing existing space, the report said.
What comes next
For the local biotech cluster, the near-term test is whether PABC can turn those empty benches into paying tenants, whether that is startups recalibrating their footprints or service firms that want ready-to-go labs. The center continues to market open lab and office space and programming to help companies grow, per PABC, and is expected to lean on state programs and its incubator network to recruit companies in the coming months.
